OBJECTIVE: To use dynamic light scattering to clinically assess early precataractous lens protein changes. METHODS: We performed a cross-sectional study in 380 eyes of 235 patients aged 7 to 86 years with Age-Related Eye Disease Study clinical nuclear lens opacity grades 0 to 3.8. A dynamic light-scattering device was used to assess alpha-crystallin, a molecular chaperone protein shown to bind other damaged lens proteins, preventing their aggregation. The outcome measure was the alpha-crystallin index, a measure of unbound alpha-crystallin in each lens. The association of the alpha-crystallin index with increasing nuclear opacity and aging was determined. RESULTS: There was a significant decrease in the alpha-crystallin index associated with increasing nuclear lens opacity grades (P < .001). There were significant losses of alpha-crystallin even in clinically clear lenses associated with aging (P < .001). The standard error of measurement was 3%. CONCLUSIONS: Dynamic light scattering clinically detects alpha-crystallin protein loss even in clinically clear lenses. alpha-Crystallin index measurements may be useful in identifying patients at high risk for cataracts and as an outcome variable in clinical lens studies. CLINICAL RELEVANCE: The alpha-crystallin index may be a useful measure of the protective alpha-crystallin molecular chaperone reserve present in a lens, analogous to creatinine clearance in estimating renal function reserve.
OBJECTIVE: To use dynamic light scattering to clinically assess early precataractous lens protein changes. METHODS: We performed a cross-sectional study in 380 eyes of 235 patients aged 7 to 86 years with Age-Related Eye Disease Study clinical nuclear lens opacity grades 0 to 3.8. A dynamic light-scattering device was used to assess alpha-crystallin, a molecular chaperone protein shown to bind other damaged lens proteins, preventing their aggregation. The outcome measure was the alpha-crystallin index, a measure of unbound alpha-crystallin in each lens. The association of the alpha-crystallin index with increasing nuclear opacity and aging was determined. RESULTS: There was a significant decrease in the alpha-crystallin index associated with increasing nuclear lens opacity grades (P < .001). There were significant losses of alpha-crystallin even in clinically clear lenses associated with aging (P < .001). The standard error of measurement was 3%. CONCLUSIONS: Dynamic light scattering clinically detects alpha-crystallin protein loss even in clinically clear lenses. alpha-Crystallin index measurements may be useful in identifying patients at high risk for cataracts and as an outcome variable in clinical lens studies. CLINICAL RELEVANCE: The alpha-crystallin index may be a useful measure of the protective alpha-crystallin molecular chaperone reserve present in a lens, analogous to creatinine clearance in estimating renal function reserve.
Authors: M Francis Simpanya; Rafat R Ansari; Kwang I Suh; Victor R Leverenz; Frank J Giblin Journal: Invest Ophthalmol Vis Sci Date: 2005-12 Impact factor: 4.799
Authors: David C Herman; Mae O Gordon; Julia A Beiser; Leo T Chylack; Kathleen A Lamping; Oliver D Schein; Joern B Soltau; Michael A Kass Journal: Am J Ophthalmol Date: 2006-11 Impact factor: 5.258
Authors: G M Thurston; D L Hayden; P Burrows; J I Clark; V G Taret; J Kandel; M Courogen; J A Peetermans; M S Bowen; D Miller; K M Sullivan; R Storb; H Stern; G B Benedek Journal: Curr Eye Res Date: 1997-03 Impact factor: 2.424
Authors: Baozhong Zhao; Colin F Chignell; Mustapha Rammal; Frank Smith; Mary G Hamilton; Usha P Andley; Joan E Roberts Journal: Photochem Photobiol Date: 2010-06-01 Impact factor: 3.421
Authors: Anbarasu Kumarasamy; Sivakumar Jeyarajan; Jonathan Cheon; Anthony Premceski; Eric Seidel; Victoria A Kimler; Frank J Giblin Journal: Exp Eye Res Date: 2018-11-15 Impact factor: 3.467